Kayleigh Brooke Bowlds Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1149 W New Hope Rd, Rogers, AR 72758 Phone: 479-636-6290 |
Chlise Hobbs Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3400 N Woods Ln, Rogers, AR 72756 Phone: 479-636-3190 Fax: 479-636-4587 |
Ashton Elizabeth Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3307 N Dixieland Rd, Rogers, AR 72756 Phone: 479-986-5150 |
Mrs. Rebecca Leblanc Jopling, M.A./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 N Dixieland Rd, Rogers, AR 72756 Phone: 479-631-3670 |
Mrs. Cassandra Ann Watts, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Poplar St, Rogers, AR 72756 Phone: 479-631-7678 Fax: 479-631-8886 |
Mrs. Linda Carol Parsons, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2510 W Hudson Rd, Rogers, AR 72756 Phone: 479-936-1061 Fax: 855-812-1132 |
Communication Partners Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16770 Heritage Bay Rd, #g7, Rogers, AR 72756 Phone: 479-925-2826 Fax: 479-925-2826 |
Tasha Roe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Woods Lane, Rogers, AR 72757 Phone: 479-636-3190 |
Carlee Kline Barker, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2703 W Gum St, Rogers, AR 72758 Phone: 989-854-1169 |
Mandi Leann Burcham, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2801 Wellington Cir Apt E3, Rogers, AR 72758 Phone: 479-790-0120 |
Mary Claire Maier, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2510 W Hudson Rd, Rogers, AR 72756 Phone: 479-936-1061 Fax: 855-812-1132 |
Janet Simpson, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2802 W Langmead Dr, Rogers, AR 72758 Phone: 417-343-5476 |
Mikayla Bakalemwa, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Poplar St, Rogers, AR 72756 Phone: 479-631-7678 |
Woodson Therapies Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2610 W Chateau Dr, Rogers, AR 72758 Phone: 479-806-1939 |
Mrs. Adrienne Marie Harr, M.ED.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2403 Marylane Dr, Rogers, AR 72756 Phone: 479-790-7979 Fax: 479-631-8993 |
Katherine Candland Perez, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2100 West Perry Rd, Rogers, AR 72758 Phone: 479-631-3515 Fax: 479-202-9105 |
Nancy Mitchell Cash, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2510 W Hudson Rd, Rogers, AR 72756 Phone: 479-936-1061 |
Lori Enos Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2301 W Walnut St, Suite 8-10, Rogers, AR 72756 Phone: 479-631-7678 |
Miss Rosemary Hart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2926 S 1st St, Russell Jones Elementary, Rogers, AR 72758 Phone: 479-631-3535 |
Ms. Ruth Joan Fadely, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Play Strong Pediatric Therapy, 3625 W. Chestnut St., Rogers, AR 72756 Phone: 479-246-0101 Fax: 479-246-0606 |
News Archive
The statistical method is significant because when researchers announce they have sequenced an organism's genome, they really mean that they have created a mosaic of two chromosomes, said USC computational biologist Lei Li.
At the 57th Experimental Nuclear Magnetic Resonance Conference (www.enc-conference.org), Bruker is showcasing several innovative drug discovery, drug development and process control solutions for small molecule NMR characterization in the chemical and pharmaceutical industries.
Insmed Incorporated, a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE™ (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA).
Masimo announced today the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Research Hospital in Ankara, Turkey investigated the role that noninvasive, continuous Masimo PVi® might play in monitoring volume status and volume changes in spontaneously breathing patients undergoing hemodialysis.
A new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk for triple-negative breast cancer, providing the basis for better risk management.
› Verified 7 days ago